CL2019003179A1 - Elimination of serine proteases by treatment with finely divided silicon dioxide. (divisional request 201203291) - Google Patents
Elimination of serine proteases by treatment with finely divided silicon dioxide. (divisional request 201203291)Info
- Publication number
- CL2019003179A1 CL2019003179A1 CL2019003179A CL2019003179A CL2019003179A1 CL 2019003179 A1 CL2019003179 A1 CL 2019003179A1 CL 2019003179 A CL2019003179 A CL 2019003179A CL 2019003179 A CL2019003179 A CL 2019003179A CL 2019003179 A1 CL2019003179 A1 CL 2019003179A1
- Authority
- CL
- Chile
- Prior art keywords
- serine proteases
- serine
- plasma
- elimination
- treatment
- Prior art date
Links
Landscapes
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
MÉTODOS PARA REDUCIR EL CONTENIDO DE SERINA PROTEASAS Y/O DE ZIMÓGENOS DE SERINA PROTEASAS DE UNA COMPOSICIÓN DE PROTEÍNAS DERIVADAS DE PLASMA. TAMBIÉN SE PROVEEN MÉTODOS DE ELABORACIÓN DE COMPOSICIONES DE PROTEÍNAS DERIVADAS DE PLASMA CON UN CONTENIDO REDUCIDO DE SERINA PROTEASAS Y/O DE ZIMÓQENOS DE SERINA PROTEASAS. ENTRE OTROS ASPECTOS, LA PRESENTE INVENCIÓN PROVEE COMPOSICIONES ACUOSAS Y LIOFILIZADAS DE PROTEÍNAS DERIVADAS DE PLASMA CON UN CONTENIDO REDUCIDO DE SERINA PROTEASAS Y/O ZIMÓQENOS DE SERINA PROTEASAS. OTROS ASPECTOS INCLUYEN MÉTODOS PARA TRATAR, MANEJAR Y/O PREVENIR UNA ENFERMEDAD QUE COMPRENDE LA ADMINISTRACIÓN DE UNA COMPOSICIÓN DE PROTEÍNAS DERIVADAS DE PLASMA CON UN CONTENIDO REDUCIDO DE SERINA PROTEASAS O DE ZIMÓQENOS DE SERINA PROTEASAS.METHODS FOR REDUCING THE CONTENT OF SERINE PROTEASAS AND / OR OF SERINE PROTEASES ZYMOGEN FROM A COMPOSITION OF PROTEINS DERIVED FROM PLASMA. IT ALSO PROVIDES METHODS FOR THE ELABORATION OF PROTEIN COMPOSITIONS DERIVED FROM PLASMA WITH A REDUCED CONTENT OF SERINE PROTEASAS AND / OR OF SERINE PROTEASES ZYMOCENES. AMONG OTHER ASPECTS, THE PRESENT INVENTION PROVIDES AQUEOUS AND LYOPHILIZED COMPOSITIONS OF PROTEINS DERIVED FROM PLASMA WITH A REDUCED CONTENT OF SERINE PROTEASES AND / OR ZYMOQENES OF SERINE PROTEASES. OTHER ASPECTS INCLUDE METHODS TO TREAT, MANAGE AND / OR PREVENT A DISEASE INVOLVING THE ADMINISTRATION OF A COMPOSITION OF PLASMA-DERIVED PROTEINS WITH A REDUCED CONTENT OF SERINE PROTEASES OR SERINE PROTEAS ZYMOQENES.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2010202125A AU2010202125B1 (en) | 2010-05-26 | 2010-05-26 | A method to produce an immunoglobulin preparation with improved yield |
US45636510A | 2010-05-27 | 2010-05-27 | |
US12/842,944 US8304524B2 (en) | 2009-07-23 | 2010-07-23 | Manufacture of factor H (FH) and FH-derivatives from plasma |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2019003179A1 true CL2019003179A1 (en) | 2020-03-06 |
Family
ID=70006135
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2019003179A CL2019003179A1 (en) | 2010-05-26 | 2019-11-06 | Elimination of serine proteases by treatment with finely divided silicon dioxide. (divisional request 201203291) |
Country Status (1)
Country | Link |
---|---|
CL (1) | CL2019003179A1 (en) |
-
2019
- 2019-11-06 CL CL2019003179A patent/CL2019003179A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6660439A2 (en) | Removal of serine protease by treatment with finely divided silicone dioxide | |
WO2011150284A3 (en) | Removal of serine proteases by treatment with finely divided silicon dioxide | |
BR112013028440A2 (en) | compositions and methods comprising serine protease variants | |
BR112013027963A2 (en) | "Subtilisin variant with proteolytic activity, nucleic acid, expression vector, host cell, composition and cleaning method". | |
MX2023008320A (en) | Cleaning and disinfecting composition. | |
MX2010004454A (en) | Anti-pcsk9 and methods for treating lipid and cholesterol disorders. | |
ECSP045191A (en) | "NEW PEPTIDES AS INHIBITORS OF THE SERINE PROTEASE NS3 OF THE VIRUS OF HEPATITIS C" | |
MX339402B (en) | Compositions and methods comprising serine protease variants. | |
MX351414B (en) | Pharmaceutical composition for treatment and/or prevention of pancreatic cancer. | |
BR112015010104A2 (en) | THERMOLYSIN ENZYME VARIANT, COMPOSITION AND CLEANING METHOD | |
PH12014500053A1 (en) | Proteasome inhibitors | |
WO2008033562A3 (en) | Kinase inhibitor compounds | |
NO20064976L (en) | Azanidols useful as inhibitors of rock and other protein kinases | |
CR9949A (en) | 5-LIPOXYGENASE ACTIVATING PROTEIN INHIBITORS (FLAP) | |
NZ601521A (en) | Trypsin-like serine protease inhibitors, and their preparation and use | |
ATE497961T1 (en) | COMPOUNDS SUITABLE AS PROTEIN KINASE INHIBITORS | |
EP2069377A4 (en) | Methods and compositions for the treatment of skin diseases and disorders | |
JO2963B1 (en) | Reconstituted Surfactants Having Improved Properties | |
MX2010002769A (en) | Recombinant preparation of selected bromelain fractions. | |
MX2014012285A (en) | Methods for treating or preventing influenza virus infection by administering a serine protease inhibitor. | |
MA32183B1 (en) | Hydroxylamine pyrimidylcyclopentane is used as akt protein kinase inhibitors | |
MX2013004906A (en) | Novel specific hcv ns3 protease inhibitors. | |
TW200730190A (en) | New combination to treat liver fibrosis | |
MX2018012178A (en) | Conjugated c1 esterase inhibitor and uses thereof. | |
ATE528309T1 (en) | COMPOUNDS SUITABLE AS PROTEIN KINASE INHIBITORS |